<?xml version="1.0" encoding="UTF-8"?>
<ref id="B49-pharmaceuticals-12-00147">
 <label>49.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lin</surname>
    <given-names>S.C.</given-names>
   </name>
   <name>
    <surname>Kappes</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>C.C.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>T.T.</given-names>
   </name>
  </person-group>
  <article-title>Distinct susceptibility and applicability of MDCK derivatives for influenza virus research</article-title>
  <source>PLoS ONE</source>
  <year>2017</year>
  <volume>12</volume>
  <elocation-id>e0172299</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0172299</pub-id>
  <pub-id pub-id-type="pmid">28207898</pub-id>
 </element-citation>
</ref>
